Toll-Like Receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy

Int Immunopharmacol. 2022 Jan:102:108398. doi: 10.1016/j.intimp.2021.108398. Epub 2021 Dec 1.

Abstract

One of the most common diabetic microvascular complications is diabetic neuropathy (DN). Immune cell infiltration in the peripheral nerve system (PNS), myelin loss, Schwann cell death, and axonal damage are all hallmarks of DN, which is currently believed to be a chronic inflammatory disease. Toll-like receptors (TLRs) are found in various types of nervous system cells, including Schwann cells, microglia, oligodendrocytes, astrocytes, and neurons. Proinflammatory mediators released at the end of TLR signal transduction can trigger an inflammatory response involving the nervous system. Studies on the association between TLRs and DN began as early as 2004. Since then, several studies have been conducted to assess the involvement of TLRs in the pathogenesis of DN. The focus of this review is to give a complete summary of the researches that have been done in this context, as well as an overview of the role of TLRs and their therapeutic applications in DN.

Keywords: Diabetes; Diabetic neuropathy; Inflammation; Inflammatory mediators; TLR.

Publication types

  • Review

MeSH terms

  • Animals
  • Diabetic Neuropathies / drug therapy*
  • Humans
  • Toll-Like Receptors / physiology
  • Toll-Like Receptors / therapeutic use*

Substances

  • Toll-Like Receptors